211 related articles for article (PubMed ID: 16011517)
1. Autoreactivity to self H-2Kb peptides in TAP1 mice. Intravenous administration of H-2Kb class I-derived peptides induces long-term survival of grafts from C57BL/6 donors.
Marrero I; Benvenutti LA; Kalil J; Coelho V
Immunology; 2005 Aug; 115(4):484-94. PubMed ID: 16011517
[TBL] [Abstract][Full Text] [Related]
2. Rejection of grafts with no H-2 disparity in TAP1 mutant mice: CD4 T cells are important effector cells and self H-2b class I molecules are target.
Suárez IM; Benvenutti LA; Noronh I; Van Kaer L; Kalil J; Coelho V
Transpl Immunol; 2002 May; 9(2-4):101-10. PubMed ID: 12180815
[TBL] [Abstract][Full Text] [Related]
3. TAP1-/- mice present oligoclonal BV-BJ expansions following the rejection of grafts bearing self antigens.
Marrero I; Huffman D; Kalil J; Sercarz EE; Coelho V
Immunology; 2006 Aug; 118(4):461-71. PubMed ID: 16895555
[TBL] [Abstract][Full Text] [Related]
4. Rejection of grafts without histocompatibility antigen disparity by TAP1-/- mice: a role for CD4+ T cells.
Marrero I; Benvenutti LA; Noronha I; Kalil J; Coelho V
Transplant Proc; 2004 May; 36(4):999-1000. PubMed ID: 15194347
[TBL] [Abstract][Full Text] [Related]
5. T-cell receptor expression in C57BL/6 mice that reject or are rendered tolerant to bm1 cardiac grafts.
Mohiuddin M; Ruggiero V; Shen Z; DiSesa VJ
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):310-3. PubMed ID: 8751496
[TBL] [Abstract][Full Text] [Related]
6. Peptides of a major histocompatibility complex class I (Kb) molecule cause prolongation of skin graft survival and induce specific down-regulatory T cells demonstrable in the mixed lymphocyte reaction.
Brondz BD; Kazansky DB; Chernyshova AD; Ivanov VS
Immunology; 1995 Oct; 86(2):219-23. PubMed ID: 7490121
[TBL] [Abstract][Full Text] [Related]
7. Self major histocompatibility complex class I antigens expressed solely in lymphoid cells do not induce tolerance in the CD4+ T cell compartment.
Schulz R; Mellor AL
J Exp Med; 1996 Oct; 184(4):1573-8. PubMed ID: 8879232
[TBL] [Abstract][Full Text] [Related]
8. MHC class I expression and CD8+ T cell development in TAP1/beta 2-microglobulin double mutant mice.
Ljunggren HG; Van Kaer L; Sabatine MS; Auchincloss H; Tonegawa S; Ploegh HL
Int Immunol; 1995 Jun; 7(6):975-84. PubMed ID: 7577806
[TBL] [Abstract][Full Text] [Related]
9. TAP1-deficient mice select a CD8+ T cell repertoire that displays both diversity and peptide specificity.
Sandberg JK; Chambers BJ; Van Kaer L; Kärre K; Ljunggren HG
Eur J Immunol; 1996 Feb; 26(2):288-93. PubMed ID: 8617293
[TBL] [Abstract][Full Text] [Related]
10. Visualization of the in vivo generation of donor antigen-specific effector CD8+ T cells during mouse cardiac allograft rejection: in vivo effector CD8+ T cell generation during allograft rejection.
Gilot BJ; Hara M; Jones ND; van Maurik A; Niimi M; Hadjianastassiou V; Morris PJ; Wood KJ
Transplantation; 2000 Feb; 69(4):639-48. PubMed ID: 10708123
[TBL] [Abstract][Full Text] [Related]
11. Rejection of allogeneic and syngeneic but not MHC class I-deficient tumor grafts by MHC class I-deficient mice.
Freland S; Chambers BJ; Andersson M; Van Kaer L; Ljunggren HG
J Immunol; 1998 Jan; 160(2):572-9. PubMed ID: 9551890
[TBL] [Abstract][Full Text] [Related]
12. Peripheral tolerance in transgenic mice expressing class I MHC L(d) only on cardiac cells.
Margenthaler JA; Kataoka M; Flye MW
Transpl Immunol; 2004 Jan; 12(2):133-41. PubMed ID: 14967311
[TBL] [Abstract][Full Text] [Related]
13. Differential reactivity of residual CD8+ T lymphocytes in TAP1 and beta 2-microglobulin mutant mice.
Ljunggren HG; Van Kaer L; Ashton-Rickardt PG; Tonegawa S; Ploegh HL
Eur J Immunol; 1995 Jan; 25(1):174-8. PubMed ID: 7843229
[TBL] [Abstract][Full Text] [Related]
14. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of acquired thymic unresponsiveness to renal allografts. Thymic recognition of immunodominant allo-MHC peptides induces peripheral T cell anergy.
Sayegh MH; Perico N; Gallon L; Imberti O; Hancock WW; Remuzzi G; Carpenter CB
Transplantation; 1994 Jul; 58(2):125-32. PubMed ID: 8042230
[TBL] [Abstract][Full Text] [Related]
16. Differential involvement of CD4+ cells in mediating skin graft rejection against different amounts of transgenic H-2K(b) antigen.
Kawai M; Obata Y; Hamasima N; Takahashi T; Uenaka A; Monden M; Mori T; Shiku H; Nakayama E
J Exp Med; 1991 Jan; 173(1):261-4. PubMed ID: 1670639
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of natural killer cell-mediated bone marrow graft rejection by allogeneic major histocompatibility complex class I, but not class II molecules.
Ohlén C; Höglund P; Sentman CL; Carbone E; Ljunggren HG; Koller B; Kärre K
Eur J Immunol; 1995 May; 25(5):1286-91. PubMed ID: 7774631
[TBL] [Abstract][Full Text] [Related]
18. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
Chen BG; Liu Z; Wu Y
Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
[TBL] [Abstract][Full Text] [Related]
19. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
[TBL] [Abstract][Full Text] [Related]
20. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
